SRSF3 and breast carcinoma: As a potential diagnostic and prognostic biomarker, SRSF3 is overexpressed in various types of cancer, including cancer of the breast, retinoblastoma, ovarian cancer, gastric cancer, head and neck cell squamous, colorectal cancer, cervical cancer and hepatocellular carcinoma (HCC).